Pharma Innovation and the IRA: Report on the Top 19 Companies from the First Half of 2023

Back to Resources
ATIWork
11/16/2023
AUTHOR – ATI Advisory

Since the Inflation Reduction Act (IRA) was passed in 2022, significant discussion has been devoted to its potential consequences for the development of new drugs. This report examines whether the IRA has had immediate impacts on drug development in the first half of 2023 through analysis of the companies’ R&D investments and M&A and licensing activities.

Recent Work

Work

Health Equity Perspectives from Individuals Experiencing LTSS Needs, and their Caregivers, from Historically Marginalized Communities

ATI Advisory’s qualitative research highlights the experiences of individuals with long-term services and supports (LTSS) needs and their caregivers in requesting, receiving, and providing LTSS. Using a community-based participatory framework in partnership with local organizations, ATI conducted six focus groups interviewing individuals and caregivers from key populations across race, ethnicity, language ability, gender identity, sexual orientation, and disability status about their experiences with LTSS. Discussions generated themes around barriers to accessing LTSS, insights on family and professional caregiving across cultures, financial constraints, the value of social community for individuals and their caregivers, and the impacts of equitable and inequitable LTSS. This work was supported by the Robert Wood Johnson Foundation.
Read More Read More
Work

Pharmaceutical Innovation and the Inflation Reduction Act: 2023 in Review 

We’re back for our half-year check-in on pharma R&D, our first since CMS selected the first 10 drugs for Medicare negotiation. In this report, we examine how 19 of the largest biopharma companies approached investment in R&D, M&A, and licensing in 2023.
Read More Read More
Work

Health Equity in Long-Term Services and Supports: Robert Wood Johnson Foundation Project Results and Findings

Approximately 14 million adults in the United States need long-term services and supports (LTSS) to help with their cognitive and functional needs. How many of these individuals have access to LTSS? What are their experiences like? What are the disparities by race and ethnicity, gender, age, and sexual identity?
Read More Read More
See more Work
Share
LinkedIn / /